Shilei Yang

461 total citations
23 papers, 329 citations indexed

About

Shilei Yang is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Shilei Yang has authored 23 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Shilei Yang's work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Shilei Yang is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Shilei Yang collaborates with scholars based in China and South Korea. Shilei Yang's co-authors include Deshi Dong, Yanna Zhu, Xiaohan Zhai, Xufeng Tao, Zhihao Liu, Qiang Meng, Xiaokui Huo, Changyuan Wang, Huijun Sun and Linlin Lv and has published in prestigious journals such as Molecules, International Journal of Pharmaceutics and RSC Advances.

In The Last Decade

Shilei Yang

21 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shilei Yang China 11 102 69 65 42 41 23 329
Yanna Zhu China 12 103 1.0× 134 1.9× 96 1.5× 39 0.9× 68 1.7× 17 350
Pajaree Chariyavilaskul Thailand 12 66 0.6× 53 0.8× 63 1.0× 93 2.2× 60 1.5× 53 424
Qianzhou Lv China 13 112 1.1× 54 0.8× 75 1.2× 14 0.3× 40 1.0× 41 428
Giuseppe Luna Australia 13 99 1.0× 24 0.3× 64 1.0× 60 1.4× 27 0.7× 25 407
B. Kevin Park United Kingdom 10 95 0.9× 91 1.3× 111 1.7× 44 1.0× 160 3.9× 15 416
Koichiro Atsuda Japan 14 109 1.1× 90 1.3× 60 0.9× 12 0.3× 35 0.9× 64 532
Ahmed A. Shaaban Egypt 14 173 1.7× 53 0.8× 33 0.5× 21 0.5× 80 2.0× 31 497
Sheng‐Wen Wu Taiwan 14 224 2.2× 72 1.0× 33 0.5× 30 0.7× 30 0.7× 42 550
Shinji Kobuchi Japan 13 122 1.2× 198 2.9× 61 0.9× 10 0.2× 60 1.5× 61 529
Honggang Lou China 11 109 1.1× 68 1.0× 73 1.1× 8 0.2× 49 1.2× 60 467

Countries citing papers authored by Shilei Yang

Since Specialization
Citations

This map shows the geographic impact of Shilei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilei Yang more than expected).

Fields of papers citing papers by Shilei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilei Yang. The network helps show where Shilei Yang may publish in the future.

Co-authorship network of co-authors of Shilei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shilei Yang. A scholar is included among the top collaborators of Shilei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilei Yang. Shilei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zuo, Yufang, Shilei Yang, Xufeng Tao, et al.. (2025). Contribution and expression of renal drug transporters in renal cell carcinoma. Frontiers in Pharmacology. 15. 1466877–1466877. 3 indexed citations
2.
3.
Han, Jinming, Xiaohan Zhai, Yunming Li, et al.. (2025). Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER-2-positive breast cancer based on the FAERS database. Breast Cancer Research. 27(1). 54–54. 2 indexed citations
4.
5.
6.
Li, Lu, Shilei Yang, Fengqi Fang, et al.. (2024). The value of second-line anti-HER2 therapy in metastatic HER-2 positive patients: a cost-effectiveness analysis in China. Frontiers in Pharmacology. 15. 1382120–1382120. 1 indexed citations
7.
Tao, Xufeng, Xiaohan Zhai, Zirui Zhao, et al.. (2023). Naringin against doxorubicin‐induced hepatotoxicity in mice through reducing oxidative stress, inflammation, and apoptosis via the up‐regulation of SIRT1. Environmental Toxicology. 38(5). 1153–1161. 22 indexed citations
8.
Zhai, Xiaohan, Xufeng Tao, Shilei Yang, et al.. (2023). Success stories of natural product-derived compounds from plants as multidrug resistance modulators in microorganisms. RSC Advances. 13(12). 7798–7817. 14 indexed citations
9.
Tao, Xufeng, Xiaohan Zhai, Yanna Zhu, et al.. (2023). Application of aptamer-drug delivery system in the therapy of breast cancer. Biomedicine & Pharmacotherapy. 161. 114444–114444. 42 indexed citations
10.
Tao, Xufeng, et al.. (2023). Machine Learning Techniques Applied to the Study of Drug Transporters. Molecules. 28(16). 5936–5936. 10 indexed citations
11.
Tao, Xufeng, et al.. (2023). Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters. Molecules. 28(13). 5252–5252. 6 indexed citations
12.
13.
Zhao, Zirui, Shilei Yang, Yawen Deng, et al.. (2022). Naringin Interferes Doxorubicin-Induced Myocardial Injury by Promoting the Expression of ECHS1. Frontiers in Pharmacology. 13. 859755–859755. 12 indexed citations
14.
Chen, Mingming, Shilei Yang, Yu Wu, et al.. (2021). High temperature requirement A1 in cancer: biomarker and therapeutic target. Cancer Cell International. 21(1). 513–513. 5 indexed citations
15.
Yang, Shilei, Zhihao Liu, Changyuan Wang, et al.. (2018). Piperacillin enhances the inhibitory effect of tazobactam on β-lactamase through inhibition of organic anion transporter 1/3 in rats. Asian Journal of Pharmaceutical Sciences. 14(6). 677–686. 4 indexed citations
16.
17.
Yang, Shilei, Yongguo Dai, Zhihao Liu, et al.. (2018). Involvement of organic cation transporter 2 in the metformin-associated increased lactate levels caused by contrast-induced nephropathy. Biomedicine & Pharmacotherapy. 106. 1760–1766. 7 indexed citations
18.
Wang, Changyuan, Xiaokui Huo, Qiang Meng, et al.. (2017). OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam. International Journal of Pharmaceutics. 537(1-2). 172–182. 47 indexed citations
19.
Huang, Di, Changyuan Wang, Qiang Meng, et al.. (2016). Protective effects of formononetin against rhabdomyolysis-induced acute kidney injury by upregulating Nrf2 in vivo and in vitro. RSC Advances. 6(112). 110874–110883. 10 indexed citations
20.
Jin, Qing‐Ri, Won‐Sik Shim, Min‐Koo Choi, et al.. (2009). Decreased urinary secretion of belotecan in folic acid-induced acute renal failure rats due to down-regulation of Oat1 and Bcrp. Xenobiotica. 39(10). 711–721. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanna Zhu Breakdown of academic impact, for papers by Pajaree Chariyavilaskul Breakdown of academic impact, for papers by Qianzhou Lv Breakdown of academic impact, for papers by Giuseppe Luna Breakdown of academic impact, for papers by B. Kevin Park Breakdown of academic impact, for papers by Koichiro Atsuda Breakdown of academic impact, for papers by Ahmed A. Shaaban Breakdown of academic impact, for papers by Sheng‐Wen Wu Breakdown of academic impact, for papers by Shinji Kobuchi Breakdown of academic impact, for papers by Honggang Lou
Rankless by CCL
2026